Table 1 Patient characteristics and inflammation activity
From: Heparanase upregulation by colonic epithelium in inflammatory bowel disease
Ulcerative colitis (n=17) | Crohn's disease (n=17) | Infectious colitis (n=8) | |
|---|---|---|---|
Age at diagnosis (years, mean±s.d.) | 32.9±19.7 | 27.4±15.9 | NA |
Males (%) | 13 (76) | 9 (53) | 6 (75) |
Disease duration before surgery/endoscopy (years, mean±s.d.) | 6.6±8.5 | 6.1±6.6 | 2.3 weeks |
Indication for surgery | Intractable disease: 12/17 | Intractable disease: 4/17 | NA |
IBD surveilance: 2/17 | Bowel obstruction: 5/17 | ||
IBD exacerbation: 2/17 | Severe dysplasia: 1/17 | ||
Bowel obstruction: 1/7 | Disease penetration: 6/17 | ||
Unknown: 1/17 | |||
Type of surgery | Total proctocolectomy: 13/17 | Rt hemicolectomy: 12/17 | NA |
Colonoscopy: 4/17 | Lt. hemicolectomy: 2/17 | ||
Total colcetomy: 2/17 | |||
Sigmoidectomy: 1/17 | |||
Disease extent | Proctitis: 0/17 | Terminal ileum: 2/17 | NA |
Left-sided colitis: 4/17 | Ileo-colic: 11/17 | ||
Pancolitis: 13/17 | Colon-only: 4/17 | ||
Disease behavior | NA | Inflammatory: 4/17 | NA |
Penetrating: 7/17 | |||
Stricturing: 6/17 | |||
Inflammation activity score (mean±s.d.) | 1.88±0.82 | 0.74±0.69 | 1.62±0.52 |
